NovAccess Global Inc. Stock Other OTC
Equities
XSNX
US67001N1072
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.17M 2.98M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.37M | Net income 2023 | -4M -5.49M | EV / Sales 2022 | - |
Net Debt 2022 | 1.41M 1.94M | Net Debt 2023 | 2.36M 3.24M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.16
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 20-10-14 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 21-09-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 20-10-14 | |
Jason Anderson
BRD | Director/Board Member | 50 | 22-03-17 |
John Cassarini
CHM | Chairman | 57 | 22-03-13 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+47.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |